Opens in a new tab

Hologic v Siemens Healthineers (CFI, 21 May 2025)

Date21 May 2025
CourtCFI
DivisionDüsseldorf (DE) Local Division
Type of actionGeneric application
Registry referenceApp_16529/2025 · ORD_17624/2025
PartiesSiemens Healthcare SAS, Siemens Healthcare GmbH, Siemens Healthineers AG, Siemens Healthineers Nederland B.V.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 21 May 2025, the Düsseldorf Local Division dismissed Siemens’ application for security for costs against Hologic, a US company suing it for infringement of EP 2 352 431 B1 (UPC_CFI_758/2024, with the counterclaim for revocation UPC_CFI_259/2025). The order confirms that a counterclaimant may seek security, but makes clear that difficulty of enforcement abroad must be proven, including the content of the foreign law.

Question

Does Hologic’s domicile in the United States (Massachusetts) make enforcement of a costs order unduly burdensome, so as to justify security of EUR 600,000 per proceeding?

Decision

The Division first held the application admissible: Rule 158.1 is not confined to the defendant in the main action, which disposed of Hologic’s objection to a counterclaimant applying. On the merits, the applicant need not show that enforcement is impossible, only that it would be unduly burdensome, but the burden is on the applicant, who must establish the foreign law and how it is applied. Siemens had offered only argument on Massachusetts law, with no evidence, so the application failed. The Division added that US courts routinely recognise and enforce foreign judgments. It left open the calculation of the amount, while doubting that two ceilings could be applied cumulatively.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 69(4)
Rules of Procedure
Rule 158.1
Case law cited
Munich Local Division, 23 April 2024, UPC_CFI_514/2023, Court of Appeal, 17 September 2024, UPC_CoA_218/2024, Aarke v SodaStream Industries, 29 November 2024, Düsseldorf Local Division, 3 December 2024, UPC_CFI_140/2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La division locale de Düsseldorf déclare recevable mais rejette la demande de garantie des frais de Siemens, faute de preuve du droit du Massachusetts et d'une difficulté excessive d'exécution aux États-Unis.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 352 431Mentioned in the analysis (role not qualified)
Also mentioned in 4 other decision(s): Hologic v Siemens Healthineers (CFI, 10 June 2026) · Siemens Healthineers v Hologic (CoA, 15 July 2026) · Hologic v Siemens Healthineers (CFI, 9 March 2026) · Hologic v Siemens Healthcare (CFI, 26 August 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.